Skip to main content
Joseph Pidala, MD, Oncology, Tampa, FL, H. Lee Moffitt Cancer Center and Research Institute

JosephAPidalaMDPhD

Oncology Tampa, FL

Hematologic Oncology

Blood and Marrow Transplantation

Overview of Dr. Pidala

Dr. Joseph Pidala is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from University of South Florida Morsani College of Medicine and has been in practice 13 years. Dr. Pidala accepts several types of health insurance, listed below. He is one of 171 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. He has more than 100 publications and over 500 citings.

Education & Training

  • University of South Florida Morsani
    University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2007 - 2010
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2004 - 2007
  • University of South Florida College of Medicine
    University of South Florida College of MedicineClass of 2004

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2010 - 2026
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Equate, a Phase 1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of a Novel Targeted Anti-CD6 Therapy, Itolizu...
    Joseph Pidala, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Early Broad-Spectrum Antibiotics and Risk of Acute Graft-Versus-Host Disease in Children: An Analysis from the Center for International Blood and Marrow Transplantatio...
    Joseph Pidala, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Impact of TBI-Based Conditioning Regimen on Outcomes of Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplant: Systematic Revi...
    Joseph Pidala, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Press Mentions

  • Phase 1 Trial Demonstrates Encouraging Clinical Benefit and Promising Safety Profile of Pacritinib for the Prevention of Graft-Versus-Host Disease Published in Clinical Cancer Research
    Phase 1 Trial Demonstrates Encouraging Clinical Benefit and Promising Safety Profile of Pacritinib for the Prevention of Graft-Versus-Host Disease Published in Clinical Cancer ResearchMarch 22nd, 2021
  • Several Factors May Affect Immune Suppression Discontinuation After HCT
    Several Factors May Affect Immune Suppression Discontinuation After HCTSeptember 26th, 2019
  • Race, Ethnicity Affect Likelihood of Finding a Suitable Unrelated Stem Cell Donor for Cancer Patients
    Race, Ethnicity Affect Likelihood of Finding a Suitable Unrelated Stem Cell Donor for Cancer PatientsSeptember 11th, 2012
  • Join now to see all

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    AvMed Health Open Access
    BCBS Blue Card PPO
    BCBS California PPO
    BCBS Florida BlueCare HMO
    BCBS Florida NetworkBlue
    BCBS Florida Preferred Patient Care PPO
    Blue Shield California PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Coventry Florida - Employer Group PPO
    First Health PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    Sagamore Health Plus
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment